Disclosed herein are novel compounds and methods for the treatment of disorders
of the lower urinary tract. The novel compounds are diarylalkylpiperazine derivatives.
The methods comprise the administration of the novel compounds of the invention,
and other compounds that bind to 5HT1A receptors, for treating disorders
of the lower urinary tract.
